BILL vs Tipalti for Medspa and Outpatient Clinic Groups

A multi-location medspa group that lumps every vendor together loses the ability to answer two very different questions it needs answered regularly: is this location's consumable spend in line with how many treatments it's actually performing, and are the group's equipment financing obligations current and on schedule. Neither question gets easier to answer inside a single undifferentiated payables view, which is why the split described below is worth setting up before choosing a platform, not after. Getting this right early also saves a painful reclassification project later, once a year of mixed spend data is already sitting in the books.

Injectable products, skincare devices' consumable components and other treatment supplies need frequent, often weekly, reordering and should be visible by location so you can spot a location over-ordering relative to its treatment volume. Equipment financing, laser devices, body contouring systems, is a handful of large, infrequent payments with a completely different rhythm. Treating both as generic 'vendor bills' in one undifferentiated list makes it hard to spot either kind of problem, an over-ordering location or a financing payment that's about to trigger a rate change.

Once consumables are tagged separately, set a per-location reorder authority similar to how a multi-location retail or dental operation would, a clinical director can reorder routine consumables up to a set amount without escalation, with anything above that requiring a second approval. BILL's role-based approval limits handle this well and are the simpler setup if your consumable vendors are predominantly domestic medical and aesthetic suppliers, which is typical.

Equipment financing payments are usually fixed, scheduled and tied to a lease or loan agreement rather than an ordinary invoice, so they don't need the same approval scrutiny every month, just a reliable recurring payment that doesn't get missed. Set these up as scheduled recurring payments in whichever platform you use, separate from the discretionary approval chain that governs consumable reordering, so a routine financing payment never accidentally sits in an approval queue behind something less time-sensitive.

Some injectable and pharmaceutical products carry additional documentation requirements depending on your state and the specific product, licensure verification, storage compliance records, that a general AP platform won't track on its own. Build a document-attachment requirement into the approval chain for these vendors specifically, similar to how a hazmat freight operation gates payment on a current compliance certificate, so the requirement is enforced at the point of payment rather than relying on someone remembering to check it separately.

If your consumable and equipment vendors are entirely domestic, which is common since most aesthetic device manufacturers and pharmaceutical distributors serving US practices operate domestically even when the underlying manufacturer is overseas, BILL's setup speed is the practical choice. Tipalti becomes relevant mainly if you're importing devices or products directly from an international manufacturer rather than through a domestic distributor, which is the exception rather than the rule for most practices.

Run the new setup, consumable ordering limits, scheduled equipment payments, compliance document requirements, at one location for a full month before extending it to the rest of the group. That gives you a real read on whether the reorder limits you set are actually calibrated to that location's treatment volume before you commit the whole practice group to numbers you're still guessing at. A single location's month of data is worth more than any vendor's suggested default setting.

A reorder limit set before you had real consumption data will usually be wrong in one direction or the other, too tight for a busy location's actual pace, too loose for a slower one. After the pilot month, compare each location's actual consumable spend against the limit you set and adjust location by location rather than applying one company-wide number, since treatment mix and volume genuinely differ across locations even within the same practice group.

What to compare after the pilot month:

• Compare each location's actual consumable spend against the reorder limit you set for it.
• Loosen limits for busy locations and tighten them for slower ones based on real usage.
• Confirm equipment financing payments run as reliable scheduled payments that never get missed.
• Check that compliance documents were attached at payment for regulated product vendors.